Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Kala Pharmaceuticals Inc (KALA)

14.99 0.06 (0.4%)

01-22 16:00

Open:

14.85

Pre. Close:

14.93

High:

15.22

Low:

14.76

Volume:

385,156

Market Cap:

368M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.227 - 15.319

15.319 - 15.407

Low:

14.545 - 14.652

14.652 - 14.755

Close:

14.825 - 14.984

14.984 - 15.135

Technical analysis  (as of: 2018-01-22 4:25:30 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 19.83     One year: 23.56

Support:

Support1: 11.81    Support2: 9.83

Resistance:

Resistance1: 16.98    Resistance2: 20.17

Pivot:

15.40

Moving Averages:

MA(5): 15.46     MA(20): 16.09

MA(100): 19.40     MA(250):

MACD:

MACD(12,26): -0.79     Signal(12,26,9): -0.84

%K %D:

%K(14,3): 39.51     %D(3): 42.92

RSI:

RSI(14): 44.12

52-Week:

High: 26.75  Low: 10.43  Change(%): 36.9

Average Vol(K):

3-Month: 31434  10-Days 58326

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
KALA has closed above bottom band by 44.8%. Bollinger Bands are 26.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 05 Jan 2018 13:02:32 GMT
Kala Pharma shares fall on mixed results from dry eye drug trials

Mon, 22 Jan 2018 18:00:00 GMT
Investors Feeling Jittery About ARCA biopharma, Inc. (ABIO), Kala ...

Wed, 17 Jan 2018 21:33:45 GMT
A Follow-Up On Kala After Mixed Phase III Results

Mon, 22 Jan 2018 16:41:15 GMT
Technical picture – Kala Pharmaceuticals, Inc. (KALA) stock price comparison ...

Fri, 19 Jan 2018 23:26:15 GMT
Kala Pharmaceuticals Inc (KALA) Major Shareholder Purchases $3193627.52 in Stock

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector: 

Industry: 

Shares Out. (M)

24.52

Shares Float (M)

24.04

% Held by Insiders

2.00

% Held by Institutions

60.50

Shares Short (K)

1181

Shares Short Prior Month (K)

383

Stock Financials

EPS

-0.560

EPS Est. Current Year

-1.920

EPS Est. Next Year

-1.860

EPS Est. Next Quarter

Forward EPS

-1.890

Book Value (p.s.)

3.700

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-31.9

Return on Equity (ttm)

-39.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.558

Qtrly Earnings Growth

Operating Cash Flow (M)

-34.86

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-26.77

P/E Growth Ratio

P/BV

4.05

P/S

P/CF

-10.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.